Sleep Apnea and Liver Health: New Research Highlights Circadian Rhythm Disruption

Nearly a billion people worldwide are affected by sleep apnea – or sleep apnea-hypopnea syndrome (SAHOS) – a disorder characterized by repeated breathing pauses during sleep. While continuous positive pressure (CPAP) therapy remains the standard treatment for moderate to severe cases, with approximately 1.8 million people in France currently utilizing it, emerging research reveals a deeper connection between sleep apnea and overall health, specifically impacting the liver’s metabolic processes.

How Sleep Apnea Disrupts the Body’s Internal Clock

Sleep apnea causes intermittent hypoxia, episodes of reduced oxygen levels. A recent study published in Science Advances on February 25, 2026, by researchers at Grenoble Alpes University, Inserm, and Grenoble Alpes University Hospital, demonstrates that these hypoxic events can reorganize the liver’s biological clock, altering its daily metabolic rhythms. The research team utilized a mouse model of chronic intermittent hypoxia to analyze the effects of sleep apnea on the body throughout the entire day-night cycle, focusing on the liver as the central organ of energy regulation.

Metabolic Reprogramming in the Liver

The study found that intermittent hypoxia alters key energy pathways, including glucose and lipid metabolism. More significantly, it profoundly modifies the circadian organization of the liver. Researchers observed that nearly half of the hepatic metabolites exhibit a 24-hour rhythm, and over a third acquire a new rhythm under intermittent hypoxia. This redistribution of metabolic rhythms reflects a temporal reprogramming of hepatic activity, a dimension of sleep apnea previously underestimated according to Inserm.

Implications for Chronomedicine and Drug Timing

These findings open new avenues for research in chronomedicine, a developing field that aims to tailor medical treatments to an individual’s circadian rhythms. The metabolic reprogrammings induced by sleep apnea may influence the body’s response to certain medications, particularly those affecting blood sugar or lipid metabolism. The study’s authors suggest that integrating the temporal dimension into the management of sleep apnea is crucial, potentially requiring a re-evaluation of optimal medication timing for individuals with the condition.

The Broader Impact of Sleep on Cardiovascular Health

The link between sleep disorders and cardiovascular risk is well-established. Beyond sleep apnea, factors like sleep deficit and insomnia are also associated with increased risk of cardiovascular diseases and stroke. Research from Inserm U1148 indicates that approximately one in five participants in a large French population-based cohort have a high likelihood of obstructive sleep apnea, yet only 3.5% are currently treated for the disorder, highlighting a significant underdiagnosis issue.

Key Takeaways

• Sleep apnea can disrupt the liver’s circadian rhythm, altering metabolic processes.
• Intermittent hypoxia, a hallmark of sleep apnea, leads to reprogramming of hepatic activity.
• Chronomedicine offers a potential framework for personalized sleep apnea management, considering individual circadian rhythms.
• The timing of medication administration may need to be adjusted for individuals with sleep apnea.
• Underdiagnosis of sleep apnea remains a significant public health concern.